Genomic Health Inc (GHDX) CFO G Bradley Cole Sold $3.1 million of Shares
CFO of Genomic Health Inc (30-Year Financial, Insider Trades) G Bradley Cole (insider trades) sold 43,112 shares of GHDX on 09/10/2019 at an average price of $72.22 a share. The total sale was $3.1 million.
Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer. Genomic Health Inc has a market cap of $2.72 billion; its shares were traded at around $72.98 with a P/E ratio of 55.76 and P/S ratio of 6.59. GuruFocus has detected 1 severe warning sign with Genomic Health Inc. .
CEO Recent Trades:
President and CEO Kimberly J Popovits sold 10,000 shares of GHDX stock on 09/09/2019 at the average price of $72.53. The price of the stock has increased by 0.62% since.
President and CEO Kimberly J Popovits sold 50,000 shares of GHDX stock on 08/13/2019 at the average price of $73.76. The price of the stock has decreased by 1.06% since.
CFO Recent Trades:
CFO G Bradley Cole sold 43,112 shares of GHDX stock on 09/10/2019 at the average price of $72.22. The price of the stock has increased by 1.05% since.
Directors and Officers Recent Trades:
Chief Commercial Officer James J Vaughn sold 4,500 shares of GHDX stock on 09/09/2019 at the average price of $72.5. The price of the stock has increased by 0.66% since.
COO Frederic Pla sold 1,251 shares of GHDX stock on 08/19/2019 at the average price of $75. The price of the stock has decreased by 2.69% since.
Chief Legal Officer Jason W. Radford sold 2,181 shares of GHDX stock on 08/15/2019 at the average price of $74.13. The price of the stock has decreased by 1.55% since.
For the complete insider trading history of GHDX, click here
.This article first appeared on GuruFocus.
